Improving Outcomes in Early Menopause After Cancer

Launched by DUKE UNIVERSITY · May 13, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on helping women who experience early menopause after undergoing cancer treatment. The researchers are developing a new program led by nurse navigators to provide personalized education about menopause, support for decision-making, and skills to help manage menopause symptoms. The goal is to see if this program is easy to join, engaging, and if it leads to better knowledge and confidence about menopause compared to a standard educational program.

To participate in this trial, women must be between 18 and 44 years old, have completed their cancer treatment at least a year ago, and have not had their period for over a year. Participants will attend sessions through video calls with a nurse navigator and will complete questionnaires at the start and about 10 weeks later to track their progress. This study is not yet recruiting participants, but it aims to improve the quality of life for women dealing with early menopause after cancer.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • female (biological sex);
• • 18 to 44 years old;
• • completed cancer treatment (other than endocrine therapy) \>12 months prior to enrollment;
• • have not had a period for more than 12 months (amenorrhea);
• • able to speak and read English.
• Exclusion Criteria:
• • diagnosis of metastatic cancer;
• • visual or hearing impairment that would interfere with participation in study;
• • cognitive impairment or severe mental illness that would interfere with participation in study.